From ‘Wildfire Cancers’ to Foot-Long Clots, Dr. Ryan Cole Explains the Dangers of the Spike Protein
These people are telling the truth. The Zogby poll showed 15 per cent of people since the rollout of the shots have a new medical condition, so that’s societally significant. Well, what’s the good news on the corollary? 85 per cent were fine. A lot of people got duds as far as some rounds of the shot went, in terms of lining up in hot stadiums, with lipids turning to mush and RNA degrading.
Okay, wait a second, I’m going to stop you. This is fascinating, right? Basically you’re saying that you believe the harms aren’t greater, because people got bad vaccines.
The ones that got the dose they were supposed to get are the ones that got harmed. The other vials were degraded, and there wasn’t enough product there to actually trigger these reactions. I have some data that will be coming out. It will be published on a large platform in a couple of weeks, looking at the biochemical distribution in about 130 different vials of the ratios of different chemicals in those vials. And they’re not the same. They’re not all the same.
The good news is a lot of people are fine. Now, remember these are multi-use vials, so once that nurse puts that first one in, now she’s put oxygen in there, and you start getting oxidative stress on the ingredients, as well as the vial is warming up. The warmer it becomes, the less intact the RNA becomes. But the less that RNA is intact presents another problem.American Thought Leaders, The Epoch Times
I sit down again with pathologist Dr. Ryan Cole for an update on the alarming trends he and his colleagues have seen since the rollout of the mRNA COVID-19 vaccines, including the rise of “wildfire cancers” and the emergence of large blood clots.
“The cells don’t lie. The clots don’t lie. The damaged organs don’t lie,” Cole says.
Cole breaks down the mechanisms by which the spike protein can cause the symptoms being reported, from brain fog to reactivated Epstein-Barr virus to changes in hormonal cycles.
Subscribe to the American Thought Leaders newsletter so you never miss an episode.